1. Clozapine: risk of gastrointestinal hypomotility complications

   Unknown 30 April 2022 Pages: 1 - 1

2. Ovarian hyperstimulation syndrome due to infertility treatments

   Unknown 30 April 2022 Pages: 2 - 2

3. Pregabalin use in pregnancy: risk of congenital abnormalities

   News item 30 April 2022 Pages: 3 - 3

4. ADRs and inappropriate medication in older patients

   Clinical study 30 April 2022 Pages: 4 - 4

5. Children more likely to develop ADRs on anticonvulsant polytherapy

   Unknown 30 April 2022 Pages: 5 - 5

6. Comparison of ADR reporting systems in nine countries

   Unknown 30 April 2022 Pages: 6 - 6

7. Direct-acting antivirals have differing effects on renal function

   Clinical study 30 April 2022 Pages: 7 - 7

8. Hydroxyzine initiation after safety advisories in UK and Canada

   Clinical study 30 April 2022 Pages: 8 - 8

9. No increased risk for venous thromboembolism after COVID-19 vaccination

   Clinical study 30 April 2022 Pages: 9 - 9

10. Ruxolitinib for GVHD: no unexpected serious AEs in EAP

    Clinical study 30 April 2022 Pages: 10 - 10

11. Safety profile of mRNA vaccines during first 6 months of the US COVID-19 vaccination programme reviewed

    Clinical study 30 April 2022 Pages: 11 - 11

12. Toxicity profiles of ALK inhibitors differ

    Clinical study 30 April 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 30 April 2022 Pages: 13 - 13

14. 17DD-yellow-fever-vaccine/immune-globulin

    Case report 30 April 2022 Pages: 14 - 14

15. Abatacept/immunosuppressants/ruxolitinib

    Case report 30 April 2022 Pages: 15 - 15

16. Abiraterone acetate/onvansertib

    Case report 30 April 2022 Pages: 16 - 16

17. Aceclofenac

    Case report 30 April 2022 Pages: 17 - 17

18. Acetylcysteine/paracetamol

    Case report 30 April 2022 Pages: 18 - 18

19. Aciclovir/dexamethasone/remdesivir

    Case report 30 April 2022 Pages: 19 - 19

20. Ad26.cov2-s

    Case report 30 April 2022 Pages: 20 - 20

21. Ad26.cov2-s

    Case report 30 April 2022 Pages: 21 - 21

22. Adalimumab

    Case report 30 April 2022 Pages: 22 - 22

23. Adalimumab

    Case report 30 April 2022 Pages: 23 - 23

24. Aflibercept/bevacizumab/ranibizumab

    Case report 30 April 2022 Pages: 24 - 24

25. Agalsidase-β/carbamazepine

    Case report 30 April 2022 Pages: 25 - 25

26. Alpelisib

    Case report 30 April 2022 Pages: 26 - 26

27. Alteplase/heparin

    Case report 30 April 2022 Pages: 27 - 27

28. Ambroxol/levocetirizine/tipepidine-hibenzate interactions

    Case report 30 April 2022 Pages: 28 - 28

29. Amiodarone

    Case report 30 April 2022 Pages: 29 - 29

30. Amiodarone

    Case report 30 April 2022 Pages: 30 - 30

31. Amiodarone/immune-globulin/lidocaine

    Case report 30 April 2022 Pages: 31 - 31

32. Amitriptyline/methylphenidate

    Case report 30 April 2022 Pages: 32 - 32

33. Amoxicillin/clavulanic acid/linezolid/piperacillin/tazobactam

    Case report 30 April 2022 Pages: 33 - 33

34. Amoxicillin/clavulanic-acid

    Case report 30 April 2022 Pages: 34 - 34

35. Amphotericin-B

    Case report 30 April 2022 Pages: 35 - 35

36. Amphotericin-B liposomal/corticosteroids/nivolumab

    Case report 30 April 2022 Pages: 36 - 36

37. Amphotericin-B-liposomal/isavuconazole/voriconazole

    Case report 30 April 2022 Pages: 37 - 37

38. Amphotericin-B-liposomal/posaconazole

    Case report 30 April 2022 Pages: 38 - 38

39. Ampicillin/sulbactam

    Case report 30 April 2022 Pages: 39 - 39

40. Anastrozole/exemestane/letrozole

    Case report 30 April 2022 Pages: 40 - 40

41. Anti-epileptics

    Case report 30 April 2022 Pages: 41 - 41

42. Anti-inflammatories/immunosuppressants

    Case report 30 April 2022 Pages: 42 - 42

43. Anti-inflammatories/interferon-α/lutetium-(177lu)-oxodotreotide

    Case report 30 April 2022 Pages: 43 - 43

44. Antiacnes

    Case report 30 April 2022 Pages: 44 - 44

45. Antibacterials

    Case report 30 April 2022 Pages: 45 - 45

46. Antibacterials/antifungals/small molecules

    Case report 30 April 2022 Pages: 46 - 46

47. Antibacterials/ceftriaxone

    Case report 30 April 2022 Pages: 47 - 47

48. Antibiotics/corticosteroids

    Case report 30 April 2022 Pages: 48 - 48

49. Anticoagulants/prothrombin complex concentrate

    Case report 30 April 2022 Pages: 49 - 49

50. Antiepileptic drugs

    Case report 30 April 2022 Pages: 50 - 50